Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMXP073)

Drug Name
CQ7 Drug Info
Synonyms
cc-671; 1618658-88-0; CC671; 4-{[4-(Cyclopentyloxy)-5-(2-Methyl-1,3-Benzoxazol-6-Yl)-7h-Pyrrolo[2,3-D]pyrimidin-2-Yl]amino}-3-Methoxy-N-Methylbenzamide; SCHEMBL16476100; CHEMBL4062218; US9623028, Compound 38; BDBM317462; EX-A1868; CS-8218; 4-((4-(cyclopentyloxy)-5-(2-methylbenzo[d]oxazol-6-yl)-7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)-3-methoxy-N-methylbenzamide; HY-108709; 4-(4-(cyclopentyloxy)-5-(2- methylbenzo[d]oxazol-6-yl)-7H- pyrrolo[2,3-d]pyrimidin-2- ylamino)-3-methoxy-N- methylbenzamide; CQ7
Cross-matching ID
PubChem CID
117881270
TTD Drug ID
DMXP073

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Patented Agent(s)
Investigative Drug(s)
Download the Complete Related Drug List
Drug(s) Targeting Calmodulin-dependent kinase II (CAMKK2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
US9623028, Compound 101 DM6F7M2 N. A. N. A. Patented [1]
US9623028, Compound 79 DMMSHX4 N. A. N. A. Patented [1]
PMID22136433C20 DMI8217 Discovery agent N.A. Investigative [2]
STO609 DMZSOG2 Discovery agent N.A. Investigative [3]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Calmodulin-dependent kinase II (CAMKK2) TTV298Y KKCC2_HUMAN Inhibitor [1]

References

1 Methods of treating a cancer using substituted pyrrolopyrimidine compounds, compositions thereof. US9623028.
2 7,8-dichloro-1-oxo-beta-carbolines as a versatile scaffold for the development of potent and selective kinase inhibitors with unusual binding modes. J Med Chem. 2012 Jan 12;55(1):403-13.
3 STO-609, a specific inhibitor of the Ca(2+)/calmodulin-dependent protein kinase kinase. J Biol Chem. 2002 May 3;277(18):15813-8.